NCT06382389View on ClinicalTrials.gov

Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
DepressionNeurocognitive Disorders
Interventions
DRUG

EMONO

Exposure of Emono via facial mask

DRUG

Medical air

exposure to Medical Air

All Listed Sponsors
lead

University Hospital, Tours

OTHER